BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2298625)

  • 1. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose.
    Smit WG; Helle PA; van Putten WL; Wijnmaalen AJ; Seldenrath JJ; van der Werf-Messing BH
    Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):23-9. PubMed ID: 2298625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect.
    Lee WR; Hanks GE; Hanlon AL; Schultheiss TE; Hunt MA
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):251-7. PubMed ID: 8635930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer.
    Campostrini F; Remo A; Astati L; Zorzi M; Capodaglio G; Buffoli A; Moretti G; Della Monica B; Zanella C; Verlato G
    Strahlenther Onkol; 2020 Jul; 196(7):617-627. PubMed ID: 32166451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
    Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE).
    Wang CJ; Leung SW; Chen HC; Sun LM; Fang FM; Huang EY; Hsiung CY; Changchien CC
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):85-91. PubMed ID: 9422562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proctitis after conventional external radiation therapy for prostate cancer: importance of minimizing posterior rectal dose.
    Cho KH; Lee CK; Levitt SH
    Radiology; 1995 Jun; 195(3):699-703. PubMed ID: 7753997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms.
    Boersma LJ; van den Brink M; Bruce AM; Shouman T; Gras L; te Velde A; Lebesque JV
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):83-92. PubMed ID: 9588921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-guided intensity-modulated radiotherapy for prostate cancer: Dose constraints for the anterior rectal wall to minimize rectal toxicity.
    Peterson JL; Buskirk SJ; Heckman MG; Diehl NN; Bernard JR; Tzou KS; Casale HE; Bellefontaine LP; Serago C; Kim S; Vallow LA; Daugherty LC; Ko SJ
    Med Dosim; 2014; 39(1):12-7. PubMed ID: 24099966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric factors predicting severe radiation-induced bowel complications in patients with cervical cancer: combined effect of external parametrial dose and cumulative rectal dose.
    Huang EY; Wang CJ; Hsu HC; Hao Lin ; Chen HC; Sun LM
    Gynecol Oncol; 2004 Oct; 95(1):101-8. PubMed ID: 15385117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High accumulated doses to the inferior rectum are associated with late gastro-intestinal toxicity in a case-control study of prostate cancer patients treated with radiotherapy.
    Casares-Magaz O; Bülow S; Pettersson NJ; Moiseenko V; Pedersen J; Thor M; Einck J; Hopper A; Knopp R; Muren LP
    Acta Oncol; 2019 Oct; 58(10):1543-1546. PubMed ID: 31364905
    [No Abstract]   [Full Text] [Related]  

  • 12. Rectal dosimetric analysis following prostate brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Lief JH; Walbert HL; Blatt HJ
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1021-7. PubMed ID: 10192350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy.
    Boehmer D; Kuczer D; Badakhshi H; Stiefel S; Kuschke W; Wernecke KD; Budach V
    Strahlenther Onkol; 2006 May; 182(5):277-82. PubMed ID: 16673061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proctitis following stereotactic body radiation therapy for prostate cancer.
    Joh DY; Chen LN; Porter G; Bhagat A; Sood S; Kim JS; Moures R; Yung T; Lei S; Collins BT; Ju AW; Suy S; Carroll J; Lynch JH; Dritschilo A; Collins SP
    Radiat Oncol; 2014 Dec; 9():277. PubMed ID: 25497602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoidance of late rectal toxicity after high-dose-rate brachytherapy boost treatment for prostate cancer.
    Kragelj B; Zlatic J; Zaletel-Kragelj L
    Brachytherapy; 2017; 16(1):193-200. PubMed ID: 27908678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
    Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
    Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is argon plasma coagulation an effective and safe treatment option for patients with chronic radiation proctitis after high doses of radiotherapy?
    Hortelano E; Gómez-Iturriaga A; Ortiz-de-Zárate R; Zaballa M; Barturen Á; Casquero F; San-Miguel Í; Carvajal C; Cacicedo J; Del-Hoyo O; Lupiani J; Pérez F; Bilbao P
    Rev Esp Enferm Dig; 2014 Mar; 106(3):165-70. PubMed ID: 25007015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy.
    de Crevoisier R; Tucker SL; Dong L; Mohan R; Cheung R; Cox JD; Kuban DA
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):965-73. PubMed ID: 15989996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.